At a glance
- 25 employees across 13 countries.
- Sales teams are supported in Europe and the Middle East.
- Fast, in-country responses across time zones.
Overview
Glaukos is a world leader in ophthalmic therapies for glaucoma, corneal disorders, and retinal diseases, with technologies approved in 30+ countries. To reach more patients, they needed to expand hiring beyond existing entities while maintaining an exceptional experience for remote sales representatives who build critical physician relationships. They sought local, expert support to do both.
Challenge
Glaukos faced two linked needs: enter new markets quickly and deliver a top-tier employee experience everywhere. Because sales representatives receive extensive training and drive relationships with healthcare decision-makers, retention was paramount. The team needed clear, country-specific guidance across payroll, benefits, taxes, and labor laws—plus a way to add talent at speed wherever growth appeared—without adding strain on HR. The challenge was balancing fast expansion with precise, market-level support for a distributed, client-facing workforce.
Solution
Glaukos selected Pebl as their employer of record to handle international hiring and workforce support. In-country experts enabled quick, compliant entry to new markets while providing timely, top-level care for sales representatives—resolving questions quickly across time zones and reducing HR lift. The partnership paired market-specific benefits expertise with responsive communication, giving Glaukos the local guidance they needed to hire and support talent without building new entities or distracting teams from patient-impact work.
Outcome
Glaukos now partners with Pebl to manage employees across Europe and the Middle East, leaning on per-market benefits expertise and high-touch care—even in countries where they already have entities. The result is a stronger day-to-day experience for field teams and higher retention of heavily trained sales representatives. With a trusted partner to guide local details, Glaukos can focus on entering markets where they can help more patients—confident support is in place.